Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome



Status:Recruiting
Healthy:No
Age Range:Any
Updated:11/3/2018
Start Date:October 1, 2018
End Date:September 30, 2019
Contact:Carrie Brusseau, PharmD
Email:cbrussea@utmck.edu
Phone:865-305-9120

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this study is to compare clonidine versus phenobarbital as adjunctive therapy
in those infants who have failed monotherapy with morphine sulfate for neonatal abstinence
syndrome (NAS).


Inclusion Criteria:

- Infants greater than or equal to 35 weeks gestation age

- Admitted to the neonatal intensive care unit

- Failed monotherapy with morphine sulfate therapy

Exclusion Criteria:

- Neonatal abstinence syndrome due to iatrogenic causes

- Unable to take oral medications at any point during their treatment

- Infants in the custody of the Department of Child Protective Services with no legal
guardian identified at the time of enrollment
We found this trial at
1
site
University of Tennessee Medical Center
Knoxville, Tennessee 37920
Phone: 865-305-6711
?
mi
from
Knoxville, TN
Click here to add this to my saved trials